EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In vivo RNA-seq and infection model reveal the different infection and immune characteristics of B. pertussis strains in China

Weilun Zuo, Chen Wei, Meiyan He, Mengyao Zhang, Jiangli Liang, Xiao Ma, Na Gao, Qin Gu, Yan Ma, Jingyan Li, Shuyuan Liu, Yan Huang und 2 weitere

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1547751 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Weilun Zuo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunogenetics, Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Kunming, Yunnan, Chi…. Hauptthemen laut MEDLINE: Bordetella pertussis, Whooping Cough. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAAA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Various strains emerged in B. pertussis re-emergence, the pathogenic characteristics and mechanisms remain elusive. We aimed to explore the relationship between the in vivo transcriptome and colonization advantage of various pertussis clinical strains during the B. pertussis re-emergence.

Methods

Four pertussis strains were isolated from clinically suspected cases by active surveillance. The phylogenetic relationships of clinical strains and global isolates were compared by a genome-wide SNP-based phylogenetic tree and allele genotyping. LC-MS/MS analysis and binding affinity detection allowed the identification of expression and antigenicity of pertactin. The characteristics of infection and immunity of clinical strains were compared in a BALB/c mouse aerosol challenge model. In vivo RNA-seq analysis was performed in NSG mouse model to describe the transcriptome during infection, and verified by detecting biofilm formation and paraquat tolerance.

Results

The partial pertactin-deficient strain BP-L2 was first reported. It showed significantly enhanced tracheal colonization compared to both CS and BP-L1 strains in naive mice ( P < 0.0001 vs . CS) and exhibited superior fitness over BP-L1 in immunized mice ( P < 0.001). BP-L1 showed superior lung colonization ( P < 0.0001) and tissue-resident memory T cell induction versus BP-L2 and CS ( P < 0.001). Colonization dominance of BP-L1 in lungs and BP-L2 in trachea aligned with the pathological injury ( P < 0.05) and the inflammatory cytokine enhancement (IL-6 in lungs of BP-L1 group, P < 0.01). In vivo RNA-seq results revealed that BP-L2 significantly upregulated relA (log2FC = 2.1, FDR P-value = 0.019) and sodA (log2FC =2.4, FDR P-value = 8.61E-06) compared to BP-L1, functionally linked to enhanced stringent response and oxidative stress defense. BP-L1 exhibited significant in vivo bipA upregulation over BP-L2 (log2FC = 1.8, FDR P-value = 0.027) without concurrent biofilm enhancement ( P = 0.51 vs . BP-L2). Furthermore, the BP-L2 and BP-L3 strains of the same ptxP1-ptxA1-fhaB3 lineage showed significantly higher paraquat tolerance than other strains ( P < 0.001), showing extremely high SODs activity.

Conclusion

The emerging pertussis strains exhibit different colonization advantages in the trachea or lungs, which will influence the transmission patterns of the clinical strains. The tracheal colonization advantage of the partial pertactin-deficient strain may be associated with the overexpression of the relA and sodA in vivo infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bordetella pertussisWhooping CoughAnimalsMiceDisease Models, AnimalMice, Inbred BALB CChinaBacterial Outer Membrane ProteinsVirulence Factors, BordetellaRNA-SeqPhylogenyFemaleHumansTranscriptomeBiofilmsLung

Stichwörter der Autor:innen

Bordetella pertussisclinical strainsin vivo RNApertactin deficiencytracheal colonization

Substanzen

Bacterial Outer Membrane ProteinsVirulence Factors, Bordetellapertactin

Autor:innen und Institutionen

  • Laboratory of Immunogenetics, Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Kunming, Yunnan, China.
  • Department of Laboratory Medicine, Fujian Key Clinical Specialty of Laboratory Medicine, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, China.
  • National Health Commission (NHC) Key Laboratory of Research on Quality and Standardization of Biotech Products and National Medical Products Administration (NMPA) Key Laboratory for Quality Research and Evaluation of Bi…
  • Department of Pulmonary and Critical Care Medicine, Xishuangbanna Dai Autonomous Prefecture People's Hospital, Jinghong, Yunnan, China.
  • Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming, Yunnan, China.

Förderung

  • NIAAA NIH HHS

Zitieren

APA

Zuo, W., Wei, C., He, M., Zhang, M., Liang, J., Ma, X., Gao, N., Gu, Q., Ma, Y., Li, J., Liu, S., Huang, Y., Sun, M., & Shi, L. (2025). In vivo RNA-seq and infection model reveal the different infection and immune characteristics of B. pertussis strains in China. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1547751

Vancouver

Zuo W, Wei C, He M, Zhang M, Liang J, Ma X, et al. In vivo RNA-seq and infection model reveal the different infection and immune characteristics of B. pertussis strains in China. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1547751

BibTeX
@article{Zuo2025,
  author = {Zuo, Weilun and Wei, Chen and He, Meiyan and Zhang, Mengyao and Liang, Jiangli and Ma, Xiao and Gao, Na and Gu, Qin and Ma, Yan and Li, Jingyan and Liu, Shuyuan and Huang, Yan and Sun, Mingbo and Shi, Li},
  title = {In vivo RNA-seq and infection model reveal the different infection and immune characteristics of B. pertussis strains in China},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1547751}
}
Kostenlos starten →